Back

Outcomes of Intracoronary AAV1/SERCA2a Gene Therapy in Patients With Heart Failure With Preserved Ejection Fraction: 12-Month Results From the MUSIC-HFpEF Phase 1/2a Trial

31 August 2026 (11:15 - 11:30)
Organised by: Logo
Congress Presentation Part of: Transforming the heart: novel therapies for myocardial disease and heart failure Nonpharmacological Treatment ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Marat Fudim

Duke Clinical Research Institute, Durham (United States of America)

3 More presentations in this session

Presentation thumbnail
CIRRUS-HCM: 12-Week Evaluation of the Safety and Efficacy of the Novel Cardiac Sarcomere Modulator EDG-7500 in Nonobstructive and Obstructive Hypertrophic Cardiomyopathy
Doctor A. Owens (Philadelphia, US)
Slides Video
Presentation thumbnail
The autoregulated bioprosthetic total artificial heart in advanced biventricular failure: 180-day outcomes from the EFICAS study
Professor A. Vincentelli (Lille, FR)
Slides Video
Presentation thumbnail
Intravenous Dexrazoxane for Hemorrhagic Myocardial Infarction in STEMI: A Double-Blind, Placebo-Controlled, Sequential-Cohort Phase IIa Trial (SHIELD-MI)
Doctor K. Vora (Indianapolis, US)
Slides Video

Access the full session

Session thumbnail
Transforming the heart: novel therapies for myocardial disease and heart failure
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Gene therapy for heart failure with preserved ejection fraction
18 May 2025
thumbnail
Congress Session
Transforming heart failure with next-generation therapies and mechanisms
31 August 2026
thumbnail
Congress Presentation
GenePHIT Phase 2 baseline characteristics: a double blind, placebo-controlled trial to assess safety and efficacy of AB-1002 gene therapy in heart failure with reduced ejection fraction
29 August 2026
thumbnail
Congress Presentation
Advances in the treatment of HFpEF
20 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources